Page 49
Volume 02
Stem Cells 2019 & Pediatrics Congress 2019
November 06-07, 2019
Journal of Clinical Genetics and Genomics
November 06-07, 2019 | Tokyo, Japan
STEM CELLS AND REGENERATIVE MEDICINE
PEDIATRICS AND CHILD CARE
International Conference on
2
nd
World Congress on
&
J Clin Gen Genomics, Volume 02
Liver tissues regenerated from human tooth treats liver failure of rat cirrhosis model
and swine NASH model
K Yaegaki
and
H Ishikawa
Nippon Dental University, Japan
C
adaveric or live-donor liver transplant is only the treatment for severe liver condition. However, the number of transplantations
is very limited because of fewer available organs than number of the patients on the waiting list. The liver regeneration might be
one of the alternative. Several clinical studies employed mesenchymal stem cells from blood, adipose tissue or others to transplant
without differentiating the cells. However, Transplantation of these cells can only slow decline of hepatic function, but they cannot
treat the conditions of the liver. The objective of adult stem cell transplantations might be to launch “bridge to transplant” strategy
rather than treating liver condition. We have shown that human dental pulp stem cell demonstrates huge potential to treat lethal liver
conditions. We have previously reported we treated the biliary liver cirrhosis and acute liver injury in nude rats with transplanting the
regenerated liver tissues originated from human dental pulp. One of the most prevailing liver condition is non-alcoholic steatohepatitis
(NASH). Hence the objectives of the research is to evaluate the clinical possibility of our transplantation protocols using swine model
of progressive liver failure developed from NASH. After four weeks of transplantation of hepatocytes described from human tooth
into the spleen of 6 swine with the failure under immune suppression, we found the secondary liver in the spleen was produced, as well
the regenerated liver was produced using the original liver as scaffold. Biliary ducts are reproduced with human tissues only 4 weeks
after the transplantation. Serum albumin level recovered from 1.5g/dL to over 3.0g/dL. HPT, choline esterase, collagen type IV, ALT
and others have been dramatically improved. But any of the positive control has shown no change.
Following above we also treated rat cirrhosis model.
michiyo-y@tky.ndu.ac.jp